Clinical Trials Browser

Completed × pazopanib × Sarcoma × Clear all

NCT01931098 2025-08-11

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Phase 2 Completed

35 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01543763 2025-03-21

Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Sarcoma, Disease Progression

NCT02049905 2024-06-13

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Phase 3 Completed

433 enrolled 10 charts

Neoplasm Metastasis, Sarcoma

NCT01330966 2023-03-10

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Phase 2 Completed

47 enrolled 10 charts

Chondrosarcoma

NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Phase 2 Completed

29 enrolled 10 charts

Hemangiosarcoma, Sarcoma

NCT01468922 2022-07-01

Pazopanib and ARQ 197 for Advanced Solid Tumors

Phase 1 Completed

32 enrolled 21 charts

Neoplasms, Sarcoma

NCT02357810 2022-06-07

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Phase 2 Completed

178 enrolled 16 charts

Liposarcoma, Sarcoma, Osteosarcoma

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Phase 2 Completed

54 enrolled 12 charts

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT03139331 2021-01-05

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Phase 1 Completed

Sarcoma

NCT01956669 2020-08-12

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Phase 2 Completed

57 enrolled 22 charts

Sarcoma

NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

111 enrolled 15 charts

Hemangiosarcoma, Sarcoma

NCT02979899 2020-05-12

TAPPAS

Phase 3 Completed

128 enrolled 13 charts

Hemangiosarcoma

NCT01446809 2020-04-13

Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma

Phase NA Completed

23 enrolled 16 charts

Sarcoma

NCT01442662 2020-01-31

LMS03

Phase 2 Completed

Leiomyosarcoma, Neoplasm Metastasis

NCT01247571 2019-08-08

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

22 enrolled 8 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT01438554 2018-08-29

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Phase 1 Completed

GastrointestinalHead & NeckSarcoma

Sarcoma, Thyroid Neoplasms, Cholangiocarcinoma

NCT01995981 2017-12-19

PREDICT

Sarcoma

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Phase 1 Completed

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT01861951 2017-08-21

EPAZ

Phase 2 Completed

Sarcoma

NCT01524848 2017-05-10

PAGIST

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00459381 2017-03-15

Pazopanib in Treating Patients With Recurrent Glioblastoma

Phase 2 Completed

35 enrolled 12 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01506596 2017-02-15

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Phase 2 Completed

42 enrolled 9 charts

Liposarcoma

NCT01719302 2016-06-16

Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma

Phase 1/2 Completed

Sarcoma

NCT01323400 2016-02-25

PAZOGIST

Phase 2 Completed

GIST

NCT00297258 2016-02-03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

Phase 2 Completed

148 enrolled 8 charts

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial

NCT01985295 2015-10-09

PASART-1

Phase 1 Completed

Sarcoma

NCT00753688 2013-08-22

PALETTE

Phase 3 Completed

369 enrolled 17 charts

Sarcoma